Impact of Intravenous Aspirin Administration on Ventriculostomy-Associated Hemorrhage in Coiled Acute Subarachnoid Hemorrhage Patients

다국어 초록 (Multilingual Abstract)

Purpose Aspirin has beneficial effects on coiling, even in acute subarachnoid hemorrhage, but there is also a perceived risk of increased bleeding and, importantly, a concern regarding ventriculostomy-associated hemorrhage (VAH) in those with complicating hydrocephalus. We aimed to assess the rate and extent of VAH in patients specifically treated with procedural intravenous aspirin during endovascular coiling of ruptured intracranial aneurysms.
Materials and Methods This was a single neurovascular center retrospective observational study of consecutive patients treated over a three-year period. The rate of VAH assessed using computed tomography and clinical outcomes were compared in patients receiving intraprocedural intravenous aspirin loading (n=90) versus those that did not receive the drug (n=40).
Results There was a significantly elevated rate of VAH in patients receiving intravenous aspirin (30% vs. 2.5%, odds ratio 16.7 [95% confidence interval: 2.2–128.0], P<0.0001). The majority of VAH was <10 mm in size (70%) with the largest bleed measuring 20 mm. No hematoma required surgical evacuation. No difference in favorable outcome at discharge was demonstrated. There was no difference in mortality between the 2 groups.
Conclusion Loading with intravenous aspirin during endovascular treatment of ruptured intracranial aneurysms significantly increases the risk of VAH, but most are small with minimal impact on clinical outcome at discharge. Intravenous aspirin should probably be reserved for selected cases but should not be withheld based on risk of VAH.

참고문헌 (Reference)

1 Cagnazzo F, "Ventriculostomy-related hemorrhage in patients on antiplatelet therapy for endovascular treatment of acutely ruptured intracranial aneurysms. A meta-analysis" 43 : 397-406, 2020

2 Bruder M, "Ventriculostomy-related hemorrhage after treatment of acutely ruptured aneurysms : the influence of anticoagulation and antiplatelet treatment" 84 : 1653-1659, 2015

3 Müller A, "The incidence of catheter tract hemorrhage and catheter placement accuracy in the clear III trial" 29 : 23-32, 2018

4 Bechan RS, "Stent-assisted coil embolization of intracranial aneurysms : complications in acutely ruptured versus unruptured aneurysms" 37 : 502-507, 2016

5 van den Bergh WM, "Randomized controlled trial of acetylsalicylic acid in aneurysmal subarachnoid hemorrhage: the MASH study" 37 : 2326-2330, 2006

6 van den Bergh WM, "Magnesium and aspirin treatment in patients with subarachnoid haemorrhage. Comparison of effects after endovascular and neurosurgical aneurysm occlusion" 256 : 213-216, 2009

7 Meves SH, "Is there an ideal way to initiate antiplatelet therapy with aspirin? A crossover study on healthy volunteers evaluating different dosing schemes with whole blood aggregometry" 4 : 106-, 2011

8 Ries T, "Intravenous administration of acetylsalicylic acid during endovascular treatment of cerebral aneurysms reduces the rate of thromboembolic events" 37 : 1816-1821, 2006

9 Parkhutik V, "Influence of COX-inhibiting analgesics on the platelet function of patients with subarachnoid hemorrhage" 21 : 755-759, 2012

10 Qin G, "Increased risk of ventriculostomy-associated hemorrhage in patients treated with antiplatelet agents for stent-assisted coiling of ruptured intracranial aneurysms" 35 : 270-274, 2021

11 Sussman ES, "Hemorrhagic complications of ventriculostomy : incidence and predictors in patients with intracerebral hemorrhage" 120 : 931-936, 2014

12 Majmundar N, "Hemorrhagic complications of external ventriculostomy in the aspirin and P2Y12 response assay era" 122 : e961-e968, 2019

13 Maniker AH, "Hemorrhagic complications of external ventricular drainage" 59 (59): ONS419-ONS424, 2006

14 Gardner PA, "Hemorrhage rates after external ventricular drain placement" 110 : 1021-1025, 2009

15 Hudson JS, "External ventricular drain and hemorrhage in aneurysmal subarachnoid hemorrhage patients on dual antiplatelet therapy : a retrospective cohort study" 84 : 479-484, 2019

16 Ditz C, "Effects of post-interventional antiplatelet therapy on angiographic vasospasm, delayed cerebral ischemia, and clinical outcome after aneurysmal subarachnoid hemorrhage: a single-center experience" 2021

17 Cagnazzo F, "Antiplatelet therapy in patients with aneurysmal SAH : impact on delayed cerebral ischemia and clinical outcome. A meta-analysis" 40 : 1201-1206, 2019

18 Edwards NJ, "Antiplatelet therapy for the prevention of peri-coiling thromboembolism in high-risk patients with ruptured intracranial aneurysms" 127 : 1326-1332, 2017